<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01294098</url>
  </required_header>
  <id_info>
    <org_study_id>10-0331</org_study_id>
    <nct_id>NCT01294098</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Femoral Nerve Block in Children With a Femur Fracture</brief_title>
  <official_title>Examining the Efficacy of Femoral Nerve Block in Children With a Femoral Shaft Fracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the efficacy of the use of Marcaine in femoral nerve
      blocks and hematoma blocks for post operative pain relief for femoral shaft fractures in a
      pediatric population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children with femur fractures can have severe pain after elastic nail fixation. The current
      national standard for post operative pain control would be intravenous narcotics. In addition
      to the use of intravenous narcotics, there are two alternative methods used during the
      surgery in order to potentially decrease the pain post-operatively. These methods are
      hematoma block or a femoral nerve block. Both are proven safe and effective in children,
      however little research has been done to look at the effectiveness of these various methods
      compared to one another.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Patients were not willing to be randomized and therefore recruitment could not continue.
  </why_stopped>
  <start_date type="Actual">February 2011</start_date>
  <completion_date type="Actual">October 8, 2014</completion_date>
  <primary_completion_date type="Actual">October 8, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative Pain Scores</measure>
    <time_frame>with in the first 24 hours</time_frame>
    <description>We will be looking at post-operative pain scores to see if those in the intervention group have lower pains scores.
Wong Baker FACES pain scale:The faces correspond to numeric values from 0-5. This scale can be documented with the numeric value. The pain scale goes from 0-5 with 0 being no pain and 5 being the worst pain.
0: No Hurt
Hurts a little bit
Hurts a little more
Hurts even more
Hurts a whole lot
Hurts worst</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative Narcotic Use</measure>
    <time_frame>within first 24 horus</time_frame>
    <description>We will be looking at the amount of narcotics used after surgery to see if there is a reduction in narcotic use</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Femur Fracture Healing</measure>
    <time_frame>first year</time_frame>
    <description>we will following patients to look at fracture healing post-operatively</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Femoral Fractures</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>PCA only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>this group will only get a pain control anesthesia pump to use for post-operative pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCA and femoral nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this group will be receiving a femoral nerve block during surgery and have a PCA post-operatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCA + hematoma block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient will receive hematoma block during surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Marcaine</intervention_name>
    <description>0.75 cc/kg of 1/4% Marcaine</description>
    <arm_group_label>PCA and femoral nerve block</arm_group_label>
    <arm_group_label>PCA + hematoma block</arm_group_label>
    <other_name>bupivacaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A child with a femoral shaft fracture requiring surgical treatment and the placement
             of intramedullary nails

          -  Weight of 30-100 Kg

          -  Child must be older than 6 years old

        Exclusion Criteria:

          -  Any child that had an open fracture

          -  A child that has a pain abnormality

          -  Any child with an allergy to local anesthetic

          -  Any child with a neurological injury

          -  Any child with the inability to report pain

          -  Any child that is unable to use a PCA post-operatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. Eric Gordon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Louis Childrens Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2011</study_first_submitted>
  <study_first_submitted_qc>February 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2011</study_first_posted>
  <results_first_submitted>February 26, 2018</results_first_submitted>
  <results_first_submitted_qc>March 28, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 30, 2018</results_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Femoral Fractures</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>Pain, Postoperative</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Femoral Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>PCA Only</title>
          <description>this group will only get a pain control anesthesia pump to use for post-operative pain</description>
        </group>
        <group group_id="P2">
          <title>PCA and Femoral Nerve Block</title>
          <description>this group will be receiving a femoral nerve block during surgery and have a PCA post-operatively
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
        </group>
        <group group_id="P3">
          <title>PCA + Hematoma Block</title>
          <description>patient will receive hematoma block during surgery
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PCA Only</title>
          <description>this group will only get a pain control anesthesia pump to use for post-operative pain</description>
        </group>
        <group group_id="B2">
          <title>PCA and Femoral Nerve Block</title>
          <description>this group will be receiving a femoral nerve block during surgery and have a PCA post-operatively
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
        </group>
        <group group_id="B3">
          <title>PCA + Hematoma Block</title>
          <description>patient will receive hematoma block during surgery
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
            <count group_id="B2" value="1"/>
            <count group_id="B3" value="1"/>
            <count group_id="B4" value="2"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B2" value="13" lower_limit="13" upper_limit="13"/>
                    <measurement group_id="B3" value="8" lower_limit="8" upper_limit="8"/>
                    <measurement group_id="B4" value="10.5" lower_limit="8" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post-operative Pain Scores</title>
        <description>We will be looking at post-operative pain scores to see if those in the intervention group have lower pains scores.
Wong Baker FACES pain scale:The faces correspond to numeric values from 0-5. This scale can be documented with the numeric value. The pain scale goes from 0-5 with 0 being no pain and 5 being the worst pain.
0: No Hurt
Hurts a little bit
Hurts a little more
Hurts even more
Hurts a whole lot
Hurts worst</description>
        <time_frame>with in the first 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCA Only</title>
            <description>this group will only get a pain control anesthesia pump to use for post-operative pain</description>
          </group>
          <group group_id="O2">
            <title>PCA and Femoral Nerve Block</title>
            <description>this group will be receiving a femoral nerve block during surgery and have a PCA post-operatively
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
          </group>
          <group group_id="O3">
            <title>PCA + Hematoma Block</title>
            <description>patient will receive hematoma block during surgery
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Pain Scores</title>
          <description>We will be looking at post-operative pain scores to see if those in the intervention group have lower pains scores.
Wong Baker FACES pain scale:The faces correspond to numeric values from 0-5. This scale can be documented with the numeric value. The pain scale goes from 0-5 with 0 being no pain and 5 being the worst pain.
0: No Hurt
Hurts a little bit
Hurts a little more
Hurts even more
Hurts a whole lot
Hurts worst</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="1.1" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="O3" value=".11" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Post-operative Narcotic Use</title>
        <description>We will be looking at the amount of narcotics used after surgery to see if there is a reduction in narcotic use</description>
        <time_frame>within first 24 horus</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCA Only</title>
            <description>this group will only get a pain control anesthesia pump to use for post-operative pain</description>
          </group>
          <group group_id="O2">
            <title>PCA and Femoral Nerve Block</title>
            <description>this group will be receiving a femoral nerve block during surgery and have a PCA post-operatively
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
          </group>
          <group group_id="O3">
            <title>PCA + Hematoma Block</title>
            <description>patient will receive hematoma block during surgery
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Narcotic Use</title>
          <description>We will be looking at the amount of narcotics used after surgery to see if there is a reduction in narcotic use</description>
          <units>mg</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="14.4"/>
                    <measurement group_id="O3" value="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Femur Fracture Healing</title>
        <description>we will following patients to look at fracture healing post-operatively</description>
        <time_frame>first year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCA Only</title>
            <description>this group will only get a pain control anesthesia pump to use for post-operative pain</description>
          </group>
          <group group_id="O2">
            <title>PCA and Femoral Nerve Block</title>
            <description>this group will be receiving a femoral nerve block during surgery and have a PCA post-operatively
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
          </group>
          <group group_id="O3">
            <title>PCA + Hematoma Block</title>
            <description>patient will receive hematoma block during surgery
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
          </group>
        </group_list>
        <measure>
          <title>Femur Fracture Healing</title>
          <description>we will following patients to look at fracture healing post-operatively</description>
          <units>weeks</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>PCA Only</title>
          <description>this group will only get a pain control anesthesia pump to use for post-operative pain</description>
        </group>
        <group group_id="E2">
          <title>PCA and Femoral Nerve Block</title>
          <description>this group will be receiving a femoral nerve block during surgery and have a PCA post-operatively
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
        </group>
        <group group_id="E3">
          <title>PCA + Hematoma Block</title>
          <description>patient will receive hematoma block during surgery
Marcaine: 0.75 cc/kg of 1/4% Marcaine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lauren Westlund</name_or_title>
      <organization>Washington University School of Medicine</organization>
      <phone>314-454-5345</phone>
      <email>davislauren@wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

